Kymera Therapeutics, Inc. Profile Avatar - Palmy Investing

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages …

Biotechnology
US, Watertown [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of KYMR's Analysis
CIK: 1815442 CUSIP: 501575104 ISIN: US5015751044 LEI: - UEI: -
Secondary Listings
KYMR has no secondary listings inside our databases.